8/10/2022  9:40:04 PM Chg. +13.100 Volume Bid9:41:46 PM Ask9:41:46 PM Market Capitalization Dividend Y. P/E Ratio
424.700EUR +3.18% 366
Turnover: 150,128.200
425.100Bid Size: 59 426.500Ask Size: 59 30.11 bill.EUR 0.30% 90.94

Business description

The Sartorius Group is a leading international pharmaceutical and laboratory equipment provider with two divisions: Bioprocess Solutions and Lab Products & Services. Bioprocess Solutions with its broad product portfolio focusing on single-use solutions helps customers produce biotech medications and vaccines safely and efficiently. Lab Products & Services, with its premium laboratory instruments, consumables and services, concentrates on serving the needs of laboratories performing research and quality assurance at pharma and biopharma companies and on those of academic research institutes.
 

Management board & Supervisory board

CEO
Joachim Kreuzburg
Management board
Rainer Lehmann, Dr. René Fáber, Gerry MacKay
Supervisory board
Dr. Lothar Kappich, Manfred Zaffke, Annette Becker, Dietmar Müller, Dr. Daniela Favoccia, Hermann Jens Ritzau, Ilke Hildegard Panzer, Karoline Kleinschmidt, Petra Kirchhoff, Prof. David Raymond Ebsworth, Prof. Dr. Klaus Rüdiger Trützschler, Prof. Dr. Thomas Scheper
 

Company data

Name: Sartorius AG
Address: Otto-Brenner-Str. 20,D-37079 Goettingen
Phone: +49-551-308-0
Fax: +49-551-308-3289
E-mail: info@sartorius.com
Internet: www.sartorius.de
Industry: Technology
Sector: Other Technology Industries
Sub sector: -
End of financial year: 12/31
Free Float: 40.81%
IPO date: 7/10/1990

Investor relations

Name: Petra Kirchhoff
IR phone: +49-551-308-1686
IR Fax: -
IR e-mail: petra.kirchhoff@sartorius.com

Company calendar

CW 43 | 10/19/2022 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
72.00%
Bio-Rad Laboratories
 
28.00%